Dr. Stirling Bryan, Centre for Clinical Epidemiology & Evaluation; UBC Dept of Medicine, along with co-investigators Margaret McGregor, Najib Ayas, Jennifer Baumbusch, Mimi Doyle-Waters, Lisa Kuramoto, and Ellen Balka, received $110,000 through CIHR's pilot Expedited Knowledge Synthesis competition for their evidence synthesis on "Nurse staffing and training requirements in long-term care facilities". The 6-month project involves working with policy makers in the Saskatchewan Health Ministry to inform judgements on appropriate nurse staffing in long-term care facilities.
You are hereAbout
Dr. Etminan published a case-control study on the risk of upper gastrointestinal bleeding with oral bisphosphonates.+
Abstract Background: Gastrointestinal injuries including gastric ulcers have been reported with oral bisphosphonate therapy. However, the risk of the more serious upper gastrointestinal bleeding (UGB) especially in the community setting with these drugs is unknown. Similarly, the risk of UGB among users of both bisphosphonates and non steroidal anti-inflammatory drugs (NSAIDs) is the community is also unknown. We conducted a pharmacoepidemiologic study to explore these two questions.